Yiwen Cui

Yiwen Cui

Auto-generated profile, based on publicly available information

Yiwen Cui

National Engineering Laboratory for Clean Technology of Leather Manufacture, Sichuan University, Chengdu 610065, PR China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2022 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
NXNi Xue
Ni Xue
YCYiwen Cui
Yiwen Cui
HXHanzhong Xiao
Hanzhong Xiao
YWYujia Wang
Yujia Wang
YHYawen Huang
Yawen Huang
BSBi Shi
Bi Shi

15 October 2019 in American Journal of Perinatology Reports
Verified
Journal Article
Open access
PDF file
YCYiwen Cui
Yiwen Cui
ARAsha Rijhsinghani
Asha Rijhsinghani
Objective To assess maternal thyroid-stimulating immunoglobulin (TSI) as a predictor of neonatal thyroid hyperthyroidism in pregnancies complicated by Graves' disease. Methods This is a 10-year retrospective study of patients with a history of Graves' disease and elevated TSI activity level defined as 1.3 times the normal. All subjects underwent cordocentesis for ultrasound findings of suspected fetal thyrotoxicosis (fetal tachycardia, oligohydramnios, hydrops, and thyromegaly). Neonatal diagnosis was made based on neonatal thyroid function testing or symptoms. Results Fourteen patients were included in the study, seven with active Graves' disease requiring antithyroid drug (“ATD group”) and seven with iatrogenic hypothyroidism on levothyroxine (“levothyroxine group”). Four cases (57%) of neonatal thyrotoxicosis were diagnosed in the levothyroxine group compared with two cases (28%) in the ATD group. The lowest maternal TSI level at which a neonate did not develop hyperthyroidism was 2.6 for the levothyroxine group and 2.5 for the ATD group. The odds ratio of a neonate from the levothyroxine group developing hyperthyroidism compared with one from the ATD group is 3.3 (95% confidence interval: 0.4–30.7). Conclusion For patients with Graves' disease, those with iatrogenic hypothyroidism and TSI > 2.5 times the basal level are at the highest risk for neonatal thyrotoxicosis.

1 January 2022 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
YCYiwen Cui
Yiwen Cui
AVAnna Visser
Anna Visser
STShirng-Wern Tsaih
Shirng-Wern Tsaih
APAnna Palatnik
Anna Palatnik